1. Home
  2. TLIH vs PPCB Comparison

TLIH vs PPCB Comparison

Compare TLIH & PPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ten-League International Holdings Limited Ordinary Shares

TLIH

Ten-League International Holdings Limited Ordinary Shares

HOLD

Current Price

$5.68

Market Cap

16.2M

Sector

N/A

ML Signal

HOLD

PPCB

Propanc Biopharma Inc.

SELL

Current Price

$1.79

Market Cap

18.1M

Sector

N/A

ML Signal

SELL

Company Overview

Basic Information
Metric
TLIH
PPCB
Founded
1998
2007
Country
Singapore
Australia
Employees
N/A
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
16.2M
18.1M
IPO Year
2023
2011

Fundamental Metrics

Financial Performance
Metric
TLIH
PPCB
Price
$5.68
$1.79
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.2K
★ 160.0K
Earning Date
09-30-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$3.34
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.22
$0.06
52 Week High
$6.08
$6.79

Technical Indicators

Market Signals
Indicator
TLIH
PPCB
Relative Strength Index (RSI) 44.35 64.42
Support Level $5.22 $1.60
Resistance Level $5.90 $1.98
Average True Range (ATR) 0.37 0.18
MACD -0.00 0.14
Stochastic Oscillator 81.05 52.86

Price Performance

Historical Comparison
TLIH
PPCB

About TLIH Ten-League International Holdings Limited Ordinary Shares

Ten-League International Holdings Ltd is a Singapore-based provider of turnkey project solutions. Its business consists of sales of heavy equipment and parts, heavy equipment rental, and provision of engineering consultancy services to port, construction, civil engineering, and underground foundation industries. It currently conducts its operations through its wholly-owned subsidiaries. The equipment it provides is organized into four categories based on their functions and application scenarios, namely, foundation equipment, hoist equipment, excavation equipment, and port machinery. The company operates in Singapore and Other international countries.

About PPCB Propanc Biopharma Inc.

Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.

Share on Social Networks: